Jan. 15, 2019—Health Network Laboratories has acquired Connective Tissue Gene Tests LLC (Allentown, Pa.), a provider of molecular diagnostic testing services for inherited genetic disorders. CTGT uses its proprietary analytic methods, mutation database, and technology to provide more than 3,300 unique tests covering more than 1,000 genes.
“The acquisition of CTGT will complement HNL’s comprehensive clinical genetic laboratory service programs in cancer, infectious disease, perinatal disease, and pharmacogenomics by providing intellectual, bioinformatics, and technical synergies amongst all the molecular genetic testing laboratories of HNL, and significantly enhance our capabilities in inherited disease diagnostic services,” Jeff Wisotzkey, PhD, clinical laboratory director and scientific officer of HNL, said in a press release.
Health Network Laboratories, headquartered in Allentown, Pa., is a full-service medical laboratory providing testing and related services to physician offices, hospitals, long-term care facilities, employers, and industrial accounts. It has more than 60 patient service centers throughout Pennsylvania and New Jersey.